First use of ibrutinib for the treatment of post-transplant central nervous system graft-versus-host disease.

British journal of haematology(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要